M
Masakazu Toi
Researcher at Kyoto University
Publications - 658
Citations - 28522
Masakazu Toi is an academic researcher from Kyoto University. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 69, co-authored 578 publications receiving 23200 citations. Previous affiliations of Masakazu Toi include The Breast Cancer Research Foundation & Tokyo Metropolitan Komagome Hospital.
Papers
More filters
Journal ArticleDOI
Prognostic significance of p53, angiogenesis, and other conventional features in operable breast cancer: subanalysis in node-positive and node-negative patients.
Giampietro Gasparini,Masakazu Toi,Paolo Verderio,Girolamo Ranieri,Stefania Dante,Emanuela Bonoldi,Patrizia Boracchi,Massimo Fanelli,Takeshi Tominaga +8 more
TL;DR: In the overall series p53 expression, IMD, nodal status, ER and PgR were statistically significant prognostic indicators for both relapse-free survival (RFS) and overall survival (OS) in the final multivariate model.
Journal ArticleDOI
De-escalation of axillary surgery in early breast cancer
TL;DR: Indications for omission of completion axillary lymph node dissection in patients with two or fewer nodes containing macrometastases demand further clarification, together with the roles of preoperative imaging in defining axillary nodal burden, deselection of patients for sentinel lymph node biopsy, and provision of radiotherapy.
Journal ArticleDOI
Alteration of specific cytokine expression patterns in patients with breast cancer
Kosuke Kawaguchi,Masashi Sakurai,Yasuko Yamamoto,Eiji Suzuki,Moe Tsuda,Tatsuki R. Kataoka,Masahiro Hirata,Mariko Nishie,Takashi Nojiri,Motofumi Kumazoe,Kuniaki Saito,Kuniaki Saito,Masakazu Toi +12 more
TL;DR: A comprehensive analysis of 26 kinds of inflammatory cytokine expression patterns among 185 patients with breast cancer and 54 healthy volunteers followed by chemometric analysis identified the specific cytokine signature of metastatic patients compared to non-metastatic patients.
Journal ArticleDOI
Trastuzumab emtansine with or without pertuzumab versus trastuzumab with taxane for human epidermal growth factor receptor 2–positive advanced breast cancer: Final results from MARIANNE
Edith A. Perez,Carlos H. Barrios,Wolfgang Eiermann,Masakazu Toi,Young-Hyuck Im,Pierfranco Conte,Miguel Martín,Tadeusz Pienkowski,Xavier Pivot,Howard A. Burris,Jennifer A. Petersen,Sanne de Haas,Silke Hoersch,Monika Patre,Paul Anthony Ellis +14 more
TL;DR: The final descriptive overall survival (OS) analysis, updated safety data, and additional patient‐reported outcomes and biomarker analyses are reported.
Journal ArticleDOI
High‐resolution imaging mass spectrometry reveals detailed spatial distribution of phosphatidylinositols in human breast cancer
Masahiro Kawashima,Noriko Iwamoto,Nobuko Kawaguchi-Sakita,Masahiro Sugimoto,Takayuki Ueno,Yoshiki Mikami,Kazuya Terasawa,Taka-Aki Sato,Koichi Tanaka,Kazuharu Shimizu,Masakazu Toi +10 more
TL;DR: This study documents a novel model for phospholipid analysis of breast cancer tissues by using high‐resolution MALDI IMS and identifies candidate PIs that can describe a specific phenotype of cancer cells.